StockNews.com began coverage on shares of Catalent (NYSE:CTLT – Free Report) in a research report sent to investors on Friday ...

After holding leadership positions at contract manufacturers Patheon and Thermo Fisher Scientific, working in the food and ...

Novo Nordisk shares fell nearly 30% in the fourth quarter on disappointing clinical trial data, and other concerns. Bank of ...

Novo Holdings, the parent company of Novo Nordisk, can proceed with its planned $16.5 billion acquisition of Catalent, a leading contract drug manufacturer, after U.S. regulators declined to ...

Shares of Catalent, Inc. (NYSE:CTLT – Get Free Report) have been given an average rating of “Hold” by the seven analysts that are presently covering the company, Marketbeat.com reports. Seven analysts ...

Catalent, Inc. (“Catalent,” NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings A/S (“Novo Holdings”), a global life ...

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks The latest announcement is out from Catalent ( (CTLT)). Catalent has been acquired by Novo Holdings in an all ...

Novo Holdings (NVO) has acquired Catalent (CTLT) in a deal that closed on December 18. Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming ...

Novo Holdings can complete its $16.5 billion acquisition of contract drug manufacturer Catalent after antitrust regulators in the U.S. declined to challenge the deal before the expiry of a ...

Heating and air-conditioning equipment maker Lennox International Inc. is replacing contract drug maker Catalent Inc. in the S&P 500, S&P Dow Jones Indices said late Wednesday. Novo Nordisk’s ...